Zinner MJ - Search Results

1

RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Biochem Biophys Res Commun. 2003 Nov 21;311(3):786-92. doi: 10.1016/j.bbrc.2003.10.060. Biochem Biophys Res Commun. 2003. PMID: 14623342

2

Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.

Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE. Ito H, et al. Among authors: zinner mj. Surgery. 2003 Aug;134(2):221-6. doi: 10.1067/msy.2003.224. Surgery. 2003. PMID: 12947321

3

Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness.

Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Biochem Biophys Res Commun. 2003 Sep 19;309(2):464-8. doi: 10.1016/j.bbrc.2003.08.024. Biochem Biophys Res Commun. 2003. PMID: 12951072

4

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Oncogene. 2004 Feb 26;23(8):1539-48. doi: 10.1038/sj.onc.1207272. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(14):1157. doi: 10.1038/s41388-023-02627-4 PMID: 14661056 Retracted.

5

The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines.

Farivar RS, Gardner-Thorpe J, Ito H, Arshad H, Zinner MJ, Ashley SW, Whang EE. Farivar RS, et al. Among authors: zinner mj. J Surg Res. 2003 Dec;115(2):219-25. doi: 10.1016/s0022-4804(03)00246-4. J Surg Res. 2003. PMID: 14697287

6

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Oncogene. 2004 Jan 15;23(2):465-73. doi: 10.1038/sj.onc.1207036. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(12):939. doi: 10.1038/s41388-023-02625-6 PMID: 14724575 Retracted.

7

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Oncogene. 2004 Feb 19;23(7):1448-56. doi: 10.1038/sj.onc.1207247. Oncogene. 2004. Retraction in: Oncogene. 2023 Mar;42(12):938. doi: 10.1038/s41388-023-02626-5 PMID: 14973554 Retracted.

8

Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. Clin Cancer Res. 2004 Apr 1;10(7):2307-18. doi: 10.1158/1078-0432.ccr-1183-3. Clin Cancer Res. 2004. PMID: 15073106

9

Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.

Ito H, Duxbury M, Benoit E, Farivar RS, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE. Ito H, et al. Among authors: zinner mj. Biochem Biophys Res Commun. 2004 May 28;318(2):594-600. doi: 10.1016/j.bbrc.2004.04.070. Biochem Biophys Res Commun. 2004. PMID: 15120641

10

siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Duxbury MS, et al. Among authors: zinner mj. J Am Coll Surg. 2004 Jun;198(6):953-9. doi: 10.1016/j.jamcollsurg.2004.01.037. J Am Coll Surg. 2004. PMID: 15194078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters